Richard W Nesto

Summary

Affiliation: Lahey Clinic
Country: USA

Publications

  1. ncbi C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones
    R Nesto
    Department of Cardiovascular Medicine, Lahey Clinic, Burlington, MA 01805, USA
    Diabet Med 21:810-7. 2004
  2. ncbi Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts 02493, USA
    Am J Cardiovasc Drugs 5:379-87. 2005
  3. ncbi Obesity: a major component of the metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Harvard Medical School, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA
    Tex Heart Inst J 32:387-9. 2005
  4. ncbi Managing cardiovascular risk inpatients with metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinical Medical Center, Burlington, Massachusetts 01805, USA
    Clin Cornerstone 7:46-51. 2005
  5. ncbi Guiding clinical decisions on abdominal obesity and cardiometabolic risk
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA
    Clin Cornerstone 9:43-52; discussion 53-4. 2009
  6. ncbi In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study
    Sergio Waxman
    Lahey Clinic, Burlington, Massachusetts 01805, USA
    JACC Cardiovasc Imaging 2:858-68. 2009
  7. ncbi Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention
    Eugene H Chung
    Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Am J Cardiol 100:1052-5. 2007
  8. ncbi High yellow color intensity by angioscopy with quantitative colorimetry to identify high-risk features in culprit lesions of patients with acute coronary syndromes
    Fumiyuki Ishibashi
    Lahey Clinic Medical Center, Burlington, MA, USA
    Am J Cardiol 100:1207-11. 2007
  9. ncbi Type 2 diabetes and coronary heart disease: focus on myocardial infarction
    Rodrigo M Lago
    Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA
    Curr Diab Rep 9:73-8. 2009
  10. ncbi Clinical characteristics of tako-tsubo cardiomyopathy
    Venkatesan Vidi
    Division of Internal Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Am J Cardiol 104:578-82. 2009

Collaborators

Detail Information

Publications46

  1. ncbi C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones
    R Nesto
    Department of Cardiovascular Medicine, Lahey Clinic, Burlington, MA 01805, USA
    Diabet Med 21:810-7. 2004
    ....
  2. ncbi Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts 02493, USA
    Am J Cardiovasc Drugs 5:379-87. 2005
    ....
  3. ncbi Obesity: a major component of the metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Harvard Medical School, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA
    Tex Heart Inst J 32:387-9. 2005
  4. ncbi Managing cardiovascular risk inpatients with metabolic syndrome
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinical Medical Center, Burlington, Massachusetts 01805, USA
    Clin Cornerstone 7:46-51. 2005
    ....
  5. ncbi Guiding clinical decisions on abdominal obesity and cardiometabolic risk
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA
    Clin Cornerstone 9:43-52; discussion 53-4. 2009
    ..However, the benefits associated with the pharmacologic management of weight loss must be weighed against the potential for drug-related adverse events...
  6. ncbi In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study
    Sergio Waxman
    Lahey Clinic, Burlington, Massachusetts 01805, USA
    JACC Cardiovasc Imaging 2:858-68. 2009
    ..To determine whether catheter-based near-infrared spectroscopy (NIRS) signals obtained with a novel catheter-based system from coronaries of patients are similar to those from autopsy specimens and to assess initial safety of NIRS device...
  7. ncbi Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention
    Eugene H Chung
    Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Am J Cardiol 100:1052-5. 2007
    ..The prevalence of smoking, male gender, and family history of premature coronary artery disease were the same for the 2 groups. In conclusion, MS was highly prevalent in this population of young patients with acute myocardial infarction...
  8. ncbi High yellow color intensity by angioscopy with quantitative colorimetry to identify high-risk features in culprit lesions of patients with acute coronary syndromes
    Fumiyuki Ishibashi
    Lahey Clinic Medical Center, Burlington, MA, USA
    Am J Cardiol 100:1207-11. 2007
    ..Coronary angioscopy with quantitative colorimetry could be used to study the association between high-risk coronary lesions and future cardiovascular events...
  9. ncbi Type 2 diabetes and coronary heart disease: focus on myocardial infarction
    Rodrigo M Lago
    Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA
    Curr Diab Rep 9:73-8. 2009
    ..Aggressive medical therapy and careful modulation of glucose metabolism in the acute and follow-up phase of a myocardial infarction may favorably influence outcome...
  10. ncbi Clinical characteristics of tako-tsubo cardiomyopathy
    Venkatesan Vidi
    Division of Internal Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Am J Cardiol 104:578-82. 2009
    ..It predominantly involves the apical portion of the left ventricle and patients with this condition have a favorable outcome with appropriate medical management. The precise cause remains unclear...
  11. ncbi Myocardial infarction as a presentation of clinical in-stent restenosis
    Atasu K Nayak
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, MA 01805, USA
    Circ J 70:1026-9. 2006
    ..Renal failure and acute coronary syndromes at the initial procedure are associated with MI...
  12. ncbi Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials
    Shin Soo Yeon
    Harvard Medical School, Boston, Massachusetts, USA
    Rev Cardiovasc Med 9:1-4. 2008
  13. ncbi Retroperitoneal hemorrhage from inferior epigastric artery: value of femoral angiography for detection and management
    Akio Kawamura
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA
    Catheter Cardiovasc Interv 68:267-70. 2006
    ..We report on two cases of retroperitoneal bleeding from unintentional puncture of the inferior epigastric artery during cardiac catheterization. Femoral angiography is a valuable tool to promptly recognize this complication...
  14. ncbi Myocardial glucose transport and utilization: a target for therapeutic intervention
    Premranjan P Singh
    Harvard Medical School, Boston, MA and Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 9:106-10. 2008
    ..Optimization of cardiac metabolism could become a new target for therapeutic intervention in patients with ischemic heart disease and diabetes...
  15. ncbi Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
    Rodrigo M Lago
    Lahey Clinic Medical Center, Burlington, MA, USA
    Lancet 370:1129-36. 2007
    ..We aimed to examine the risk of congestive heart failure and of cardiac death in patients given TZDs...
  16. ncbi Influence of diabetes and/or myocardial infarction on prevalence of abnormal T-wave alternans
    David T Martin
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, MA 01805, USA
    Ann Noninvasive Electrocardiol 14:355-9. 2009
    ..The presence of diabetes (DM) is associated with an increased risk of sudden death but there is limited data on the impact of DM and previous myocardial infarction (MI) on TWA prevalence...
  17. ncbi Prevalence of newly diagnosed diabetes in clinical settings
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 7:S18-24. 2006
    ..The prevalence of hyperglycemia in patients admitted with acute cardiovascular disease and the effect of hyperglycemia on outcome are reviewed...
  18. ncbi Gastric volvulus presenting as an acute coronary syndrome
    Satish Sivasankaran
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA
    Tex Heart Inst J 33:266-8. 2006
  19. ncbi Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)
    David T Martin
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, MA 01805, USA
    Circ Heart Fail 4:332-8. 2011
    ..Data are limited regarding whether the presence of diabetes mellitus (DM) influences the benefit of cardiac resynchronization with defibrillator therapy (CRT-D) in heart failure (HF) patients...
  20. ncbi Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques
    Jay D Caplan
    InfraReDx Inc, Burlington, Massachusetts 01803, USA
    J Am Coll Cardiol 47:C92-6. 2006
    ..Additional studies are planned to validate the ability of the technique to identify lipid-rich coronary artery plaques and ultimately link chemical characterization with subsequent occurrence of an acute coronary syndrome...
  21. ncbi The relation of insulin resistance syndromes to risk of cardiovascular disease
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 4:S11-8. 2003
    ..This article reviews the relationship between diabetes and the risk of CVD...
  22. ncbi Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction
    Tina C Bansal
    Center for Sexual Function/Endocrinology, Lahey Clinic Medical Center, Burlington, MA, USA
    J Sex Med 2:96-103. 2005
    ..Early detection of metabolic disease in patients with ED may be a gateway to the reduction endothelial dysfunction in younger men with increased cardiovascular risk but who present for treatment of ED alone...
  23. ncbi Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study
    Martin K Rutter
    Framingham Heart Study, Burlington, Mass, USA
    Circulation 107:448-54. 2003
    ..Insulin resistance was associated with increased LV mass in women alone, but this relation was largely accounted for by obesity...
  24. ncbi Pharmacological treatment and prevention of heart failure in the diabetic patient
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 5:1-8. 2004
    ..B-Blockers remain underused in the diabetic population despite overwhelming evidence of their efficacy in treating heart failure in patients with diabetes...
  25. ncbi Impact of gender on in-hospital outcomes following contemporary percutaneous intervention for peripheral arterial disease
    Akio Kawamura
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA
    J Invasive Cardiol 17:433-6. 2005
    ..The purpose of this study was to assess the gender differences on in-hospital outcomes of patients undergoing PPAI...
  26. ncbi Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque
    Akira Miyamoto
    Institute for Prevention of Cardiovascular Disease, Cardiovascular Division, Department of Medicine, Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin Cardiol 27:9-15. 2004
    ..75 to 0.88). CONCLUSION: Plaque cap thickness is a determinant of plaque color, and this can be assessed by quantitative colorimetry. Thus, plaque color by angioscopy may be useful for detecting vulnerable plaques...
  27. ncbi Correlation between cardiovascular disease and diabetes mellitus: current concepts
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Am J Med 116:11S-22S. 2004
    ..Such interventions may include well-established treatments for hypertension and dyslipidemia, diet improvements, weight loss, and exercise as well as novel pharmacologic interventions aimed at newly identified therapeutic targets...
  28. ncbi Diabetes, hyperglycemia, and the cardiologist: a call to action for optimizing care. Introduction
    Richard W Nesto
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 7:S1-2. 2006
  29. ncbi Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient
    Hans K Meier-Ewert
    Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Rev Cardiovasc Med 3:S20-7. 2002
    ..The ACC/AHA 2002 guidelines for the management of acute coronary syndromes recommend the use of abciximab in diabetic patients undergoing stent implantation...
  30. ncbi A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians
    Xiaowei Ma
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
    Hum Mol Genet 13:2197-205. 2004
    ..In conclusion, this comprehensive study of CD36 variability indicates that the common polymorphisms at this locus modulate lipid metabolism and cardiovascular risk in Caucasians...
  31. ncbi Modifications of coronary risk factors
    Jeanine Albu
    The New York Obesity Research Center, St Luke s Roosevelt Hospital Center, University Hospital of Columbia University, College of Physicians and Surgeons, Columbia University, New York, New York 10025, USA
    Am J Cardiol 97:41G-52G. 2006
    ....
  32. ncbi The insulin resistance syndrome and coronary artery disease
    David M Kendall
    International Diabetes Center, Park Nicollet Clinic, 3800 Park Nicollet Blvd, St Louis Park, MN 55416, USA
    Coron Artery Dis 14:335-48. 2003
    ..A proposed approach to the management of patients with the insulin resistance syndrome is discussed...
  33. ncbi Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003
    Richard W Nesto
    Circulation 108:2941-8. 2003
  34. ncbi Cardiometabolic risk and risk management. Introduction
    Richard W Nesto
    Clin Cornerstone 8:9-10. 2007
  35. ncbi Antiplatelet therapy in populations at high risk of atherothrombosis
    David P Faxon
    Section of Cardiology, Department of Medicine, University of Chicago, 5841 S Maryland Ave, Room B 608, MC 6080, Chicago, IL 60637, USA
    J Natl Med Assoc 98:711-21. 2006
    ....
  36. ncbi Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
    John B Buse
    University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Diabetes Care 30:162-72. 2007
    ..This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ...
  37. ncbi Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: is the jury still out?
    Howard J Broder
    Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, California, USA
    Rev Cardiovasc Med 7:S44-50. 2006
    ....
  38. ncbi Diabetes and residual risk of coronary heart disease
    Richard W Nesto
    Nat Clin Pract Endocrinol Metab 3:71. 2007
  39. ncbi The platelet in diabetes: focus on prevention of ischemic events
    John A Colwell
    Diabetes Center, Medical University of South Carolina, Charleston, South Carolina, USA
    Diabetes Care 26:2181-8. 2003
    ..Recent studies support the use of clopidogrel in addition to standard therapy, as well as the use of GpIIb-IIIa inhibitors in ACS patients...
  40. ncbi Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction
    Stuart W Zarich
    Division of Cardiovascular Medicine, Bridgeport Hospital, Yale University School of Medicine, New Haven, Conn, USA
    Circulation 115:e436-9. 2007
  41. ncbi Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management: Response to Raggi et al
    Martin K Rutter
    Diabetes Care 29:1187; author reply 1188. 2006
  42. ncbi Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association
    Richard W Nesto
    American Diabetes Association
    Diabetes Care 27:256-63. 2004
  43. ncbi Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
    John B Buse
    University of North Carolina, USA
    Circulation 115:114-26. 2007
    ..This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ...
  44. ncbi Diabetes and hypertension
    Rodrigo M Lago
    Nat Clin Pract Endocrinol Metab 3:667. 2007
  45. ncbi Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration
    Brian F Johnson
    Pfizer Research, Groton, Connecticut, USA
    Diabetes Care 27:448-54. 2004
    ..There was no change in resting diastolic filling rates in either group. CONCLUSIONS: Diabetic patients with neuropathy have LV abnormalities that can be stabilized and partially reversed by ARI treatment...
  46. ncbi The CHARISMA trial and the REACH registry outcomes
    David P Faxon
    J Natl Med Assoc 98:1713. 2006